Literature DB >> 977033

On the blood group B gene-specified alpha-galactosyltransferase in the serum of the Japanese tortoise (Clemmys japonica).

Y Matsukura.   

Abstract

Human blood group O cells were converted into B-active cells by incubation at either 4 degrees or 37 degrees with uridine diphosphate D-galactose and unfractionated serum from the Japanese tortoise (Clemmys japonica). The specificity of the converted cells was tested by their reactions with human anti-B, anti-A and rabbit anti-B sera. Under the conditions used, Bombay (Oh) type cells were not converted, and group-O foetal cells possessing a few H antigenic sites were only weakly converted into B-active cells. In addition, the agglutination titre of the converted cells with eel anti-H serum decreased. These results therefore indicate that the conversion depends upon the preference of H-substance on the red cells. The alpha-galactosyltransferase in tortoise serum thus resembles the transferase in human group-B serum and these results suggest that the mechanism of biosynthesis of blood group B substance in the tortoise is similar to that in humans.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977033      PMCID: PMC1445370     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  3 in total

1.  Assay of alpha-N-acetylgalactosaminyltransferases in human sera. Further evidence for several types of Am individuals.

Authors:  J P Cartron; A Gerbal; J Badet; C Ropars; C Salmon
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

2.  The action of the blood group B gene-specified -galactosyltransferase from human serum and stomach mucosal extracts on group O and 'Bombay' O h erythrocytes.

Authors:  C Race; W M Watkins
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

3.  Biochemical, serological and family studies in individuals with Cis AB phenotypes.

Authors:  T Pacuszka; J Kościelak; H Seyfried; I Walewska
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.